White Labs

WhiteLab Genomics is a French Tech Bio company that leverages artificial intelligence and machine learning to accelerate the development of genomic medicines, including gene and cell therapies. Founded in 2019 and backed by Y Combinator, the company provides a proprietary platform that optimizes the design of viral vectors (like AAV and lentivirus) and non-viral delivery systems (like LNPs) while identifying optimal payloads and targets. WhiteLab Genomics collaborates with major pharmaceutical companies and biotech firms, such as Sanofi and Flagship Pioneering, to de-risk and expedite R&D timelines for complex diseases in areas like ophthalmology and the central nervous system. Their approach combines in silico modeling with biological data to improve the safety, efficacy, and manufacturability of next-generation genetic treatments. By integrating multi-omic data and advanced algorithms, the company aims to significantly reduce the time and cost associated with bringing life-saving genetic therapies to market.